Addex Therapeutics Ltd (NASDAQ:ADXN – Get Free Report) was the target of a significant decline in short interest in the month of January. As of January 31st, there was short interest totalling 1,500 ...
Discover seven companies operating in metabolomics, the field that could significantly boost precision medicine.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback